News

Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update

MORRISTOWN, N.J., May 15, 2017 (GLOBE NEWSWIRE) — Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced financial results for the three months ended March 31, 2017.

2017-06-20T13:55:56+00:00